BRPI0415002A - processo para preparação de compostos heterocìclicos n-amino substituìdos - Google Patents

processo para preparação de compostos heterocìclicos n-amino substituìdos

Info

Publication number
BRPI0415002A
BRPI0415002A BRPI0415002-3A BRPI0415002A BRPI0415002A BR PI0415002 A BRPI0415002 A BR PI0415002A BR PI0415002 A BRPI0415002 A BR PI0415002A BR PI0415002 A BRPI0415002 A BR PI0415002A
Authority
BR
Brazil
Prior art keywords
compound
preparing substituted
heterocyclic compounds
amino
hydrazone
Prior art date
Application number
BRPI0415002-3A
Other languages
English (en)
Inventor
Franz Weiberth
George E Lee
Reda G Hanna
Silke Dubberke
Roland Utz
Jurgen Mueller-Lehar
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of BRPI0415002A publication Critical patent/BRPI0415002A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/622Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/626Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
    • C04B35/63Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
    • C04B35/632Organic additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/86Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Manufacturing & Machinery (AREA)
  • Ceramic Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Structural Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)

Abstract

"PROCESSO PARA PREPARAçãO DE COMPOSTOS HETEROCìCLICOS N-AMINO SUBSTITUìDOS". A presente invenção refere-se a um processo aperfeiçoado para preparação de compostos N-amino nitrogênio heterocíclicos. Em uma modalidade desta invenção, um composto de fórmula (VI) é preparado começando do correspondente derivado indol, por meio de N-aminação e subseqüente formação de uma hidrazona, por reação com um ceto-composto em uma única etapa. A redução adicional da hidrazona e subseqüente acoplamento com um composto piridina rende o composto de fórmula (VI) ou um sal adequado deste.
BRPI0415002-3A 2003-10-03 2004-10-01 processo para preparação de compostos heterocìclicos n-amino substituìdos BRPI0415002A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50833503P 2003-10-03 2003-10-03
PCT/US2004/032086 WO2005035496A1 (en) 2003-10-03 2004-10-01 Process for the preparation of n-amino substituted heterocyclic compounds

Publications (1)

Publication Number Publication Date
BRPI0415002A true BRPI0415002A (pt) 2006-11-07

Family

ID=34434904

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0415002-3A BRPI0415002A (pt) 2003-10-03 2004-10-01 processo para preparação de compostos heterocìclicos n-amino substituìdos

Country Status (29)

Country Link
US (1) US7112682B2 (pt)
EP (1) EP1678135B1 (pt)
JP (1) JP2007507518A (pt)
KR (1) KR20060120028A (pt)
CN (2) CN100579963C (pt)
AR (1) AR046041A1 (pt)
AT (1) ATE431339T1 (pt)
AU (1) AU2004279808B2 (pt)
BR (1) BRPI0415002A (pt)
CA (1) CA2540867A1 (pt)
DE (1) DE602004021126D1 (pt)
DK (1) DK1678135T3 (pt)
ES (1) ES2327417T3 (pt)
HK (1) HK1095592A1 (pt)
HR (2) HRP20060124A2 (pt)
IL (1) IL174238A0 (pt)
MA (1) MA28117A1 (pt)
ME (1) MEP19508A (pt)
MX (1) MXPA06003446A (pt)
NO (1) NO20061929L (pt)
NZ (1) NZ545838A (pt)
PL (1) PL1678135T3 (pt)
PT (1) PT1678135E (pt)
RS (1) RS20060225A (pt)
RU (1) RU2364588C2 (pt)
SI (1) SI1678135T1 (pt)
TW (1) TW200519086A (pt)
WO (1) WO2005035496A1 (pt)
ZA (1) ZA200602694B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040132708A1 (en) * 2002-05-01 2004-07-08 Wyeth Process for preparing 6-alkylidene penem derivatives
AR039475A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
AR039774A1 (es) * 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
AR039476A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp Proceso para preparar derivados de 6-alquiliden penem
US7538227B2 (en) * 2004-01-13 2009-05-26 Sanofi-Aventis Deutschland Gmbh Process for stabilizing 4-halopyridines
WO2006115456A1 (en) * 2005-04-26 2006-11-02 Cambrex Karlskoga Ab Synthesis of 1-aminopiperidine
GT200600332A (es) * 2005-07-27 2007-03-14 Inhibidores de 6-alquiliden-penem beta-lactamasa triciclicos y combinación de antibióticos de b-lactama: un antibiotico de amplio espectro
PE20070403A1 (es) * 2005-07-27 2007-05-15 Wyeth Corp COMPOSICION FARMACEUTICA QUE COMPRENDE CEFEPIME Y DERIVADOS DE 6-ALQUILIDEN-PENEM BICICLICOS COMO INHIBIDORES DE ß-LACTAMASA
GT200600380A (es) * 2005-08-24 2007-03-29 Proceso para la preparacion de inhibidores de beta-lactamasa
FR2897614B1 (fr) * 2006-02-20 2008-05-23 Urogene Forme cristalline du chlorhydrate de la besipirdine, procedes de preparation et utilisations
EP2493305B1 (en) 2009-10-30 2015-03-25 Genzyme Corporation 2-aminoindole compounds and methods for the treatment of malaria
CN105753838A (zh) * 2016-02-11 2016-07-13 安阳师范学院 喹啉衍生物高区域选择性胺化新方法
CN110799523A (zh) * 2017-05-12 2020-02-14 中外制药株式会社 用于制备环状有机化合物的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0629273B2 (ja) * 1986-06-13 1994-04-20 宇部興産株式会社 N−アミノヘキサメチレンイミンの製造法
JPH01157922A (ja) * 1987-12-15 1989-06-21 Citizen Watch Co Ltd ニトリル化合物の製造方法
US5459274A (en) * 1994-05-13 1995-10-17 Hoechst-Roussel Pharmaceuticals Inc. Preparation of N-alkyl-N-pyridinyl-1H-indol-1-amines

Also Published As

Publication number Publication date
DK1678135T3 (da) 2009-09-07
HK1095592A1 (en) 2007-05-11
NZ545838A (en) 2009-01-31
PT1678135E (pt) 2009-08-21
JP2007507518A (ja) 2007-03-29
RS20060225A (en) 2008-09-29
CA2540867A1 (en) 2005-04-21
IL174238A0 (en) 2006-08-01
MXPA06003446A (es) 2006-06-14
ES2327417T3 (es) 2009-10-29
CN101391976A (zh) 2009-03-25
AU2004279808B2 (en) 2010-04-22
MEP19508A (en) 2010-06-10
WO2005035496A1 (en) 2005-04-21
US20050101654A1 (en) 2005-05-12
TW200519086A (en) 2005-06-16
RU2364588C2 (ru) 2009-08-20
ZA200602694B (en) 2007-09-26
HRP20090441T1 (en) 2009-09-30
AU2004279808A1 (en) 2005-04-21
EP1678135A1 (en) 2006-07-12
CN1890213A (zh) 2007-01-03
US7112682B2 (en) 2006-09-26
CN100579963C (zh) 2010-01-13
EP1678135B1 (en) 2009-05-13
NO20061929L (no) 2006-04-28
RU2006114667A (ru) 2006-09-10
KR20060120028A (ko) 2006-11-24
HRP20060124A2 (en) 2006-10-31
SI1678135T1 (sl) 2009-10-31
MA28117A1 (fr) 2006-08-01
PL1678135T3 (pl) 2009-10-30
AR046041A1 (es) 2005-11-23
DE602004021126D1 (de) 2009-06-25
ATE431339T1 (de) 2009-05-15

Similar Documents

Publication Publication Date Title
HRP20060124A2 (en) Process for the preparation of n-amino substituted heterocyclic compounds
BR0316146A (pt) Derivados de amida do ácido 3-(2-hidróxifenil)-1h-pirazol-4-carboxìlico como inibidores de hsp90 para o tratamento de câncer
BR122017028096B8 (pt) composto, composição farmacêutica, e, uso do composto
BRPI0608732A2 (pt) composto ou um sal, hidrato, solvato, complexo ou pró-droga farmaceuticamente aceitável do mesmo, sal de um composto, processo para a preparação de um composto, uso de um composto, composição farmacêutica, e, produto
DE60231414D1 (de) 3-substituierte 4-pyrimidonderivate
NO20060142L (no) Syklisk tertiaer aminforbindelse
BRPI0413233A (pt) novos compostos
BRPI0409938A (pt) derivados de azetidinacarboxamida e seu uso em terapia
NO20082719L (no) Aryl-isoksazol-4-yl-oksadiazolderivater
NO20082136L (no) 1,5-substituerte indol-2-yl-amidderivater
WO2006113552A8 (en) Cyanoarylamines
AR068115A1 (es) Derivado del acido pirazolcarboxilico metodo de produccion del mismo y fungicida
BRPI0414738A (pt) derivados de ácido acético substituìdos
IL186777A0 (en) (3,4-dihydro-quinazolin-2-yl) - (2-aryloxy-ethyl) - amines having an activity on the 5 - ht receptor
BR112014032229B1 (pt) método para produzir 4-[5-(piridin-4-il)-1h-1,2,4-triazol-3- il]piridina-2-carbonitrila
NO20080025L (no) Pyrazolderivater som CB1 modulatorer
BRPI0406500A (pt) processo farmacêutico e compostos preparados pelo mesmo
DE602006014022D1 (de) 5-substituierte indol-2-carbonsäureamidderivate
BRPI0508404A (pt) derivado de (indol-3-il)-heterociclo, composição farmacêutica, uso de um derivado de (indol-3-il)-heterociclo, e método de tratamento da dor
EA200700246A1 (ru) Трициклические производные пиразола в качестве модуляторов каннабиноидного рецептора
DK1877370T3 (da) Fremgangsmåde til fremstilling af hydrazon-derivater
AU2001255646A1 (en) Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives
EA200870405A1 (ru) Способ получения гетероциклических производных
Mickevičienė et al. Synthesis of some 1-and 2-carboxyalkyl substituted benzimidazoles and their derivatives
EA200400828A1 (ru) Гетероциклические замещённые фенилсодержащие сульфонамиды широкого спектра действия в качестве ингибиторов протеазы вич

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: AVENTIS PHARMACEUTICALS, INC. (US)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020070165509/RJ DE 23/11/2007.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.